HC Surgical 1B1

SGD 0.35 +0.00% +0.00 Updated 16 Nov 2026, 17:16 SGT

Company profile

The business, the people and the ownership behind HC Surgical.

Business overview

About the company

HC Surgical Specialists operates clinics and endoscopy centres in Singapore. Its services include gastroscopy, colonoscopy and general surgery, with a particular focus on colorectal surgery and procedures delivered through its network of specialist facilities.

Annual Report 2026 ↗ Reviewed 2026-10-23 · Source dated 2026-09-14. PDF p. 3

Listed security

Company & listing

Full Company Name
HC SURGICAL SPECIALISTS LIMITED
Trading Currency
SGD
Website
www.hcsurgicalspecialists.com
Listing
Listed on 3 November 2016 on SGX Catalist
ISIN Code
SG1DC2000004

Board & management

Leadership

Five current board members include Dr. Heah Sieu Min as CEO and Dr. Chia Kok Hoong as Medical Director. Two additional key management members are listed. Chong Weng Hoe stepped down as Chairman and Independent Director on 25 September 2025; his current role is Non-Independent Non-Executive Director.

MR. CHAN PENGEE, ADRIAN

Non-Executive Chairman; Independent Director

HC Surgical Specialists board

DR. HEAH SIEU MIN

Executive Director; Chief Executive Officer

HC Surgical Specialists board

DR. CHIA KOK HOONG

Executive Director; Medical Director

HC Surgical Specialists board

MR. LIM JUN XIONG STEVEN

Independent; Non-Executive Director

HC Surgical Specialists board

MR. CHONG WENG HOE

Non-Independent; Non-Executive Director

HC Surgical Specialists board

MS. SOPHIA ONG

Chief Financial Officer

HC Surgical Specialists key management

MS. MELISSA SUSANTIO

Chief Operating Officer

HC Surgical Specialists key management

Roles listed in ANNUAL REPORT 2026; current appointments are not independently verified.

Holdings

Ownership

Two substantial shareholders and twenty registered / depository holders as at 21 August 2026. The 153,375,507-share denominator excludes 2,934,400 treasury shares. The founders’ direct interests are expressly held through DBS Nominees and overlap with its registered position; they are not added to it.

Dr. Heah Sieu Min

Direct interest: 63,988,980(1) shares, 41.72%; deemed interest: – shares, –%.

Direct / deemed interests; shares held through DBS Nominees

Dr. Chia Kok Hoong

Direct interest: 34,753,440(2) shares, 22.66%; deemed interest: – shares, –%.

Direct / deemed interests; shares held through DBS Nominees

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-08-21 · PDF p. 151

Registered holderInterestShares / unitsSource
DBS NOMINEES PTE LTD103,014,420 shares; 67.16%.PDF p. 1512026-08-21
YEO KHEE SENG BENNY6,839,309 shares; 4.46%.PDF p. 1512026-08-21
MEDINEX LIMITED6,090,400 shares; 3.97%.PDF p. 1512026-08-21
LIM WEI-MIN, JASON5,214,277 shares; 3.40%.PDF p. 1512026-08-21
CITIBANK NOMINEES SINGAPORE PTE LTD3,436,384 shares; 2.24%.PDF p. 1512026-08-21
LEO TING PING RONALD3,015,629 shares; 1.97%.PDF p. 1512026-08-21
IFAST FINANCIAL PTE LTD1,554,681 shares; 1.01%.PDF p. 1512026-08-21
NG HOCK KON1,400,000 shares; 0.91%.PDF p. 1512026-08-21
APEX CAPITAL GROUP PTE LTD1,270,000 shares; 0.83%.PDF p. 1512026-08-21
CHUA CHIN HENG ALAN1,156,000 shares; 0.75%.PDF p. 1512026-08-21
PHILLIP SECURITIES PTE LTD1,077,584 shares; 0.70%.PDF p. 1512026-08-21
LIM AH KAW@LIM LAN CHING850,000 shares; 0.55%.PDF p. 1512026-08-21
UOB KAY HIAN PTE LTD628,600 shares; 0.41%.PDF p. 1512026-08-21
LAI JIUNN HERNG600,555 shares; 0.39%.PDF p. 1512026-08-21
ANG HAO YAO (HONG HAOYAO)538,000 shares; 0.35%.PDF p. 1512026-08-21
LAI WENG KAY503,400 shares; 0.33%.PDF p. 1512026-08-21
TEOU KEM ENG @TEOU KIM ENG500,000 shares; 0.33%.PDF p. 1512026-08-21
ABN AMRO CLEARING BANK N.V.489,800 shares; 0.32%.PDF p. 1512026-08-21
LAU HOOI KHENG NANCY473,500 shares; 0.31%.PDF p. 1512026-08-21
LAI JUNXU448,000 shares; 0.29%.PDF p. 1512026-08-21

Group structure

Main operating subsidiaries and other group entities

Nineteen subsidiaries are in the audited year-end schedule; one associate and two joint ventures are disclosed separately. Countries in those schedules denote principal place of business, not an inferred place of incorporation. Company ownership and NCI percentages retain both original years.

Medical L & C Services has a genuine unprinted FY2026 NCI cell; the FY2025 NCI cell is a printed dash. Neither is filled with inferred zero.

The group structure diagram prints HC (Siglap) 30% and Medistar 70%, while the audited year-end Company schedule prints 80% and 85%. Both source disclosures are retained; the undated diagram is not used to replace audited figures.

NYK is a subsequent acquisition completed with consideration paid on 1 July 2026. JLES acquired an additional 15% of MDS on 11 June 2026, making it wholly owned by the Group. These disclosures are separate from 31 May ownership.

Healthcare Essentials is a joint venture despite 20% ownership, because board decisions require unanimous approval. It reports at 31 March; appropriate adjustments are made through 31 May.

CompanyMarketOwnership interest
Heah Sieu Min (Mt E) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 Singapore; Colorectal endoscopy and piles centre; 100; 100; –; –
Heah Sieu Min (Bukit Batok) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 Singapore; Provide outpatient consultation services and procedures in the field of Colorectal Endoscopy practices; 100; 100; –; –
CKH (Farrer Park) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 Singapore; General, vein laser vascular and laparoscopy surgery and other health services; 100; 100; –; –
HC (Siglap) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 Singapore; Specialised medical services (including day surgical centres)/ clinics and other general medical services; 80; 80; 20; 20
HC (TPY) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 Singapore; Specialised medical services (including day surgical centres)/other health services; 100; 100; –; –
Malcolm Lim Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 Singapore; Clinics and other general medical services; 51; 51; 49; 49
LAI BEC Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 Singapore; Clinics and other general medical services; 51; 51; 49; 49
Hannah Medical Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 Singapore; Clinics and other general medical services; 100; 100; –; –
HC (Hillford) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 Singapore; Specialised medical services (including day surgical centres)/ clinics and other general medical services; 100; 100; –; –
HC (GM) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 Singapore; Specialised medical services (including day surgical centres)/ clinics and other general medical services; 100; 100; –; –
KPO Endoscopy & Surgery Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 Singapore; Clinics and other general medical services; 70; 70; 30; 30
Medical L & C Services Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 Singapore; Clinics and other general medical services; 100; 100; not printed; –
Medical Services @ Tampines Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 Singapore; Clinics and other general medical services/medical shared services; 100; 100; –; –
Jason Lim Endoscopy and Surgery Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 Singapore; Specialised medical services/clinics and other general medical services; 100; 100; –; –
HC (Ming) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 Singapore; Clinics and other general medical services; 100; 100; –; –
HC (AMK) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 Singapore; Clinics and other general medical services; 100; 100; –; –
GMH Endoscopy & Surgery Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 Singapore; Clinics and other general medical services; 100; 100; –; –
Medistar Services Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 Singapore; Clinics and other general medical services; 85; 85; 15; 15
Chirurgia Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 Singapore; Specialised medical services (including day surgical centres); 51; –; 49; –
NYK Endoscopy and Digestive Centre Pte. Ltd.Acquisition after FY2026 year-end, consideration paid 1 July 2026; not a 31 May 2026 subsidiaryPDF p. 1502026-07-01 Singapore; provision of endoscopic procedures; 51%
Total Orthopaedics Pte. Ltd.Held by the Company; Group effective interest FY2026 / FY2025PDF p. 1102026-05-31 Singapore; Clinics and other general medical services; 35; 35
Healthcare Essentials Pte. Ltd.Held by the Company; Group effective interest FY2026 / FY2025PDF p. 1132026-05-31 Singapore; Retail sale of pharmaceutical and medical goods/general trading of medical supplies/management consultancy services; 20; 20
HC Orthopaedics & Surgical Centre Pte. Ltd.Held by the Company; Group effective interest FY2026 / FY2025PDF p. 1132026-05-31 Singapore; Clinics and other general medical services; 50; 50
HC (Siglap)Original undated group structure diagram; differs from audited Company ownership schedulePDF p. 10 30%
MedistarOriginal undated group structure diagram; differs from audited Company ownership schedulePDF p. 10 70%
MDSJLES acquired the additional interest on 11 June 2026; year-end Company ownership remains 85%PDF p. 1502026-06-11 Additional 15%; wholly owned subsidiary of the Group

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
MS. SOPHIA ONG Chief Financial Officer PDF p. 17
MS. MELISSA SUSANTIO Chief Operating Officer PDF p. 17
MS. LEE HUI THENG Chief Nursing Officer PDF p. 17

Extracted from ANNUAL REPORT 2026 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
Number of issued and paid-up shares (excluding Treasury Shares) 153,375,507 shares Company, excluding treasury shares · As at 2026-08-21 PDF p. 151
Class of Shares Ordinary Shares Company · As at 2026-08-21 PDF p. 151
Voting rights (excluding Treasury Shares) One vote per ordinary share Company · As at 2026-08-21 PDF p. 151

Treasury shares

ItemValuePeriod / scopeSource
Number of Treasury Shares 2,934,400 shares Company · As at 2026-08-21 PDF p. 151
Number (Percentage) of Treasury Shares to total number of issued shares excluding Treasury Shares* 1.91% Company · As at 2026-08-21 PDF p. 151
Number of subsidiary holdings – shares Company · As at 2026-08-21 PDF p. 151

Shareholding distribution

ItemValuePeriod / scopeSource
Total 448 holders Total number of shareholders · As at 2026-08-21 PDF p. 151
100 - 1,000 47 holders; 10.49% of holders; 26,300 shares; 0.02% of shares Size band 100-1,000 · As at 2026-08-21 PDF p. 151
1 - 99 0 holders; 0.00% of holders; 0 shares; 0.00% of shares Size band 1-99 · As at 2026-08-21 PDF p. 151
1,001 - 10,000 165 holders; 36.83% of holders; 999,484 shares; 0.65% of shares Size band 1,001-10,000 · As at 2026-08-21 PDF p. 151
10,001 - 1,000,000 225 holders; 50.22% of holders; 18,281,039 shares; 11.92% of shares Size band 10,001-1,000,000 · As at 2026-08-21 PDF p. 151
1,000,001 and above 11 holders; 2.46% of holders; 134,068,684 shares; 87.41% of shares Size band 1,000,001 and above · As at 2026-08-21 PDF p. 151

Free float

ItemValuePeriod / scopeSource
SHAREHOLDING HELD IN HANDS OF PUBLIC approximately 30.97% Company · As at 2026-08-21 PDF p. 152
SHAREHOLDING HELD IN HANDS OF PUBLIC Rule 723 of the SGX-ST Listing Manual Section B: Rules of the Catalist is complied with Company · As at 2026-08-21 PDF p. 152

Extracted from ANNUAL REPORT 2026 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Chee & Heah Surgical Associates Pte. Ltd. 576 S$'000 FY2026 aggregate IPT value excluding transactions <S$100,000 and shareholders' mandate transactions; Associate of Dr. Heah Sieu Min (CEO) PDF p. 65
Farrer Park Holdings Pte. Ltd. 216 S$'000 FY2026 aggregate IPT value; Associate of Dr. Chia Kok Hoong (Executive Director and Medical Director) PDF p. 65
CH Hillford Investments Pte. Ltd. 162 S$'000 FY2026 aggregate IPT value; Associate of CKH PDF p. 65

Director remuneration

ItemValuePeriod / scopeSource
Dr. Heah Sieu Min 1,122,926 S$ FY2026, Executive Director/CEO total PDF p. 55
Dr. Chia Kok Hoong 637,248 S$ FY2026, Executive Director total PDF p. 55
Mr. Chong Weng Hoe 39,000 S$ FY2026, Non-Executive Director fee total PDF p. 55
S$250,001 to S$500,000 Ms. Sophia Ong FY2026 Key Management Personnel (not Directors or CEO), bands of S$250,000 PDF p. 56

Subsequent events

ItemValuePeriod / scopeSource
Acquisition of subsidiary - NYK Endoscopy and Digestive Centre Pte. Ltd. (“NYK”) On 8 June 2026, the Company entered into a sale and purchase agreement to acquire 51% of the issued and fully paid-up capital in NYK. Events subsequent to reporting date (31 May 2026) · As at 2026-06-08 PDF p. 150
Transaction with NCI On 11 June 2026, JLES had completed the acquisition of an additional 15% of the issued and fully paid up shares in MDS. Events subsequent to reporting date (31 May 2026) · As at 2026-06-11 PDF p. 150

Extracted from ANNUAL REPORT 2026 and checked against the cited pages; see the original report for full context.

Source: ANNUAL REPORT 2026 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
01 Sep 2015
Telephone
+65 6205 0345
Fax
+65 6200 1537
Registered Office
9 Raffles Place
#26-01 Republic Plaza
Singapore 048619
Secretary
Lin Moi Heyang
Tang Pei Chan
Registrar / Transfer Agent
TRICOR BARBINDER SHARE REGISTRATION SERVICES
Registrar Address
9 Raffles Place, Republic Plaza Tower I #26-01, Singapore 048619
Auditors
BDO LLP
Other Stock Exchange Listings
*SINGAPORE EXCHANGE (CATALIST)
Country
SINGAPORE
Security Type
stocks